WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Vitamin D Deficiency and Dysautonomia

Not Applicable

Completed

Conditions: Nausea
Vitamin D Deficiency
Orthostatic Intolerance

Interventions: Dietary Supplement: vitamin D supplement

First Posted Date: 2017-01-26

Last Posted Date: 2023-01-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 31

Registration Number: NCT03032328

Locations: 🇺🇸
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Not Applicable

Completed

Conditions: Stage II Laryngeal Squamous Cell Carcinoma
Stage IV Lip and Oral Cavity Squamous Cell Carcinoma
Paranasal Sinus Squamous Cell Carcinoma
Stage I Laryngeal Squamous Cell Carcinoma
Stage I Lip and Oral Cavity Squamous Cell Carcinoma
Stage III Oropharyngeal Squamous Cell Carcinoma
Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma
Stage IVB Hypopharyngeal Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Laryngeal Squamous Cell Carcinoma

Interventions: Other: Watch video
Other: Communication Intervention
Other: Module completion of the Prepare to Care kit
Other: Quality-of-Life Assessment
Other: Survey Administration
Other: Salivary cortisol collection

First Posted Date: 2017-01-26

Last Posted Date: 2023-01-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 35

Registration Number: NCT03032250

Locations: 🇺🇸
Comprehensive Cancer Center of Wake Forest University, Winston-Salem, North Carolina, United States

Mobility Assessment Using Surrogates in Elderly Participants

Completed

Conditions: Mobility Limitation

First Posted Date: 2017-01-26

Last Posted Date: 2017-12-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 130

Registration Number: NCT03032341

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Video vs. Direct Laryngoscopy in Pediatric Nasal Intubation

Not Applicable

Terminated

Conditions: Nasal Intubation

Interventions: Device: Direct Laryngoscopy
Device: Video Laryngoscopy for nasal intubation

First Posted Date: 2017-01-26

Last Posted Date: 2018-08-08

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 12

Registration Number: NCT03032263

Locations: 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Biologics Anchoring Study

Not Applicable

Completed

Conditions: Moderate-to-severe Psoriasis

Interventions: Behavioral: Intervention Group Oral Survey 2
Behavioral: Control Group Oral Survey 1

First Posted Date: 2017-01-20

Last Posted Date: 2018-06-11

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 100

Registration Number: NCT03026153

Locations: 🇺🇸
Dept of Dermatology, WFUHS, Winston-Salem, North Carolina, United States

Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer

Phase 2

Completed

Conditions: Breast - Female
Male Breast Cancer

Interventions: Drug: Pembrolizumab
Drug: Paclitaxel

First Posted Date: 2017-01-11

Last Posted Date: 2023-08-04

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 40

Registration Number: NCT03018080

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery

Phase 2

Terminated

Conditions: Postoperative Pain

Interventions: Drug: Placebo
Drug: Oxytocin

First Posted Date: 2017-01-05

Last Posted Date: 2022-11-23

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 126

Registration Number: NCT03011307

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

IINB vs. QLB for Elective Open Inguinal Herniorrhaphy

Phase 2

Completed

Conditions: Nerve Block
Herniorrhaphy
Regional Anesthesia

Interventions: Procedure: Ilioinguinal / Iliohypogastric Block
Procedure: Quadratus Lumborum Block
Drug: Bupivacaine 0.25%
Drug: Clonidine 1.66mcg/cc

First Posted Date: 2017-01-02

Last Posted Date: 2019-11-18

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 60

Registration Number: NCT03007966

Locations: 🇺🇸
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

Single Injection Adductor Canal Block Versus Continuous Adductor Canal Infusion for Total Knee Arthroplasty

Early Phase 1

Completed

Conditions: Total Knee Arthroplasty
Pain, Postoperative
Adductor Canal Block

Interventions: Procedure: Multimodal Peripheral Nerve Block Injection
Procedure: Single Shot Adductor Canal Block
Drug: Initial Bolus
Drug: Continuous infusion